These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7290777)

  • 1. Reduced concanavalin A capping of neonatal polymorphonuclear leukocytes (PMNs).
    Kimura GM; Miller ME; Leake RD; Raghunathan R; Cheung AT
    Pediatr Res; 1981 Sep; 15(9):1271-3. PubMed ID: 7290777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concanavalin a capping of rhesus monkey polymorphonuclear leukocytes.
    Cheung AT; Kimura GM; Miller ME; Walsh EM
    J Med Primatol; 1985; 14(5):285-9. PubMed ID: 4057241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous and drug induced concanavalin A capping of neutrophils from human infants and their mothers.
    Strauss RG; Hart MJ
    Pediatr Res; 1981 Sep; 15(9):1314-8. PubMed ID: 7290781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc receptor expression, concanavalin A capping, and enzyme content of bovine neonatal neutrophils: a comparative study with adult cattle.
    Zwahlen RD; Wyder-Walther M; Roth DR
    J Leukoc Biol; 1992 Mar; 51(3):264-9. PubMed ID: 1311746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pentoxifylline on developmental changes in neutrophil cell surface mobility and membrane fluidity.
    Newton JA; Ashwood ER; Yang KD; Augustine NH; Hill HR
    J Cell Physiol; 1989 Sep; 140(3):427-31. PubMed ID: 2550471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing extracellular potassium causes calcium-dependent shape change and facilitates concanavalin A capping in human neutrophils.
    Roberts RL; Mounessa NL; Gallin JI
    J Immunol; 1984 Apr; 132(4):2000-6. PubMed ID: 6699404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concanavalin A capping in polymorphonuclear leukocytes.
    Rister M; Brucke G; Wegener F; Gladtke E
    Eur J Pediatr; 1980 Dec; 135(2):153-60. PubMed ID: 7192630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of polymorphonuclear leukocyte capping by a chemotactic factor.
    Mandell BF; Spilberg I; Lichtman J
    J Immunol; 1977 Apr; 118(4):1375-8. PubMed ID: 321690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired microtubule function correctable by cyclic GMP and cholinergic agonists in the Chediak-Higashi syndrome.
    Oliver JM
    Am J Pathol; 1976 Nov; 85(2):395-418. PubMed ID: 187062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microtubule assembly and conanavalin A capping in lymphocytes: reappraisal using normal and abnormal human peripheral blood cells.
    Oliver JM; Gelfand EW; Pearson CB; Pfeiffer JR; Dosch HM
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3499-503. PubMed ID: 6968071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule function in leukocytes from umbilical cord blood.
    Fontán G; Garcia Rodriguez MC; Ojeda JA
    J Clin Lab Immunol; 1981 May; 5(3):195-6. PubMed ID: 7241570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
    Kurrasch R; Elfman F; Perez HD
    J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related differential effects of zinc on concanavalin A-induced capping of human lymphocytes.
    Rao KM
    Exp Gerontol; 1982; 17(3):205-11. PubMed ID: 7140861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C inhibitors enhance concanavalin A cap formation in polymorphonuclear leukocytes.
    Sato A; Tanabe F; Ito M; Ishida E; Shigeta S
    Int J Immunopharmacol; 1990; 12(1):121-5. PubMed ID: 2105914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permanent inhibition of capping of spleen lymphocytes from neonatally oestrogen-treated female mice.
    Kalland T; Forsberg JG
    Immunology; 1980 Feb; 39(2):281-4. PubMed ID: 7380472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the redistribution of surface-bound concanavalin A on human polymorphonuclear leukocytes.
    Ryan GB; Borysenko JZ; Karnovsky MJ
    J Cell Biol; 1974 Aug; 62(2):351-65. PubMed ID: 4426911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiol proteinase inhibitors reverse the increased protein kinase C down-regulation and concanavalin A cap formation in polymorphonuclear leukocytes from Chediak-Higashi syndrome (beige) mouse.
    Sato A; Tanabe F; Ito M; Ishida E; Shigeta S
    J Leukoc Biol; 1990 Nov; 48(5):377-81. PubMed ID: 2230592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in concanavalin A capping of human lymphocytes with age.
    Noronha AB; Antel JP; Roos RP; Arnason BG
    Mech Ageing Dev; 1980 Apr; 12(4):331-7. PubMed ID: 7392675
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of DNCB-induced irritant dermatitis by colchicine.
    Miyachi Y; Takigawa M; Imamura S
    Acta Derm Venereol; 1981; 61(4):307-11. PubMed ID: 6173985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capping of surface immunoglobulin on 'hairy cells' is independent of energy production.
    Splinter TA; Collard JG; De Wildt A; Temmink JH; Décary F
    J Cell Sci; 1979 Apr; 36():45-59. PubMed ID: 457818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.